The t(8;21) results in a chimeric oncogene AML1-ETO, resulting in expression of a fused oncoprotein AML1-ETO (AE), and is found in 20% of the AML patients [2, 7]. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.